<DOC>
	<DOC>NCT01345058</DOC>
	<brief_summary>This is a study to determine whether a combination of low dose lacosamide and levetiracetam is more effective than high dose levetiracetam in patients who have failed low dose levetiracetam.</brief_summary>
	<brief_title>Add on Lacosamide Versus High Dose Monotherapy</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Lacosamide</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>1. Adults age 18 or older 2. Determined to have had at least two partial seizures by an epilepsy specialist, or to have had a single partial seizure with clinical and/or laboratory evidence of a high seizure recurrence risk 3. Monotherapy on levetiracetam less than or equal to 1500mg/day for at least two weeks 4. Breakthrough seizure while on stable dose (&gt;5 days) of levetiracetam monotherapy regimen, not due to provocative factors (e.g. hypoglycemia, head trauma, missed medications) 1. Clinical suspicion of nonepileptic psychogenic seizures or idiopathic generalized epilepsy 2. Pregnant, childbearing age not using contraception, or breast feeding 3. Medical contraindication to adding lacosamide 4. History of AED polytherapy 5. Presence of a vagus nerve stimulator 6. Creatinine clearance of less than 50mL/min 7. Blood pressure instability: pulse&lt;50 or &gt;100, SBP&lt;50 or &gt;180, clinically significant EKG abnormality 8. History of significant drug rash or anaphylactic reaction with antiepileptic drug 9. Patients with progressive lesions (e.g. brain tumors)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Epilepsy</keyword>
	<keyword>antiepileptic drug</keyword>
	<keyword>polytherapy</keyword>
</DOC>